Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsBeyond The WallsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutSpecial ReportViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement
|Articles|December 15, 2001

Why Your Practice Should Consider Pediatric Dispensing

Are you considering adding pediatric optical dispensing to your practice?

Advertisement

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Advertisement

Related Content

Advertisement

AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision

ByMartin David Harp
November 26th 2025

AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081

ByMartin David Harp
November 25th 2025

AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives

ByMartin David Harp
November 25th 2025

Ocular Therapeutix randomizes first patient in HELIOS-3

ByMartin David Harp
November 24th 2025

AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care

ByMartin David Harp
November 24th 2025
Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision

2

AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives

3

Ocular Therapeutix randomizes first patient in HELIOS-3

4

AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081

5

AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us